AI & Machine Learning

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

With key conferences ahead, Supernus Pharmaceuticals must prove its strategy can deliver growth in the competitive central nervous system drug landscape.

Creatd Inc. executes a 1:20 reverse stock split to chase a national exchange listing. Is it a strategic masterstroke or a sign of deeper struggles?

Fintech unicorn Clear Street pulls its much-anticipated IPO, a move that highlights a tough market forcing many tech firms to reconsider public debuts.

A new partnership brings an FDA-designated breakthrough device to more patients, fueled by a key Medicare payment that could reshape the trauma market.

The cannabis giant upsizes its credit facility by CAD $15M, signaling strong lender confidence and fueling its ambitious global expansion plans.

The fusion energy pioneer plans to go public via a SPAC merger, seeking capital to prove its unique technology and win the race for limitless clean power.

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

With promising data in cancer and eczema, all eyes are on Corvus Pharmaceuticals as it presents its lead drug at a major healthcare conference this week.

A former hedge fund manager's stark video presentation warns that AI will permanently alter work and wealth. Are American workers prepared for what's next?

Following strong earnings and a major SAP settlement, Teradata will detail its AI-driven future and financial outlook at two key investor conferences.

With a new CEO and a key investor conference ahead, Metagenomi bets on its unique metagenomics platform and a hemophilia drug to navigate a tough market.

Top veterinary group endorses Visbiome Vet for chronic gut issues, setting a new evidence-based standard in a crowded, unregulated pet supplement market.

The digital media firm faces a Nasdaq compliance countdown after failing to file its annual report, revealing deeper issues of financial strain and SEC scrutiny.

As Mueller Water Products heads to a key industry symposium, a new CEO and record earnings set the stage for its vision for America's water future.

Fresh off its first profitable year and with a new CEO, Remitly launches a major investor tour to detail its ambitious diversification strategy.

A new JBF report reveals how independent restaurants are battling costs, tech, and expectations with surprising optimism and strategic shifts.

Tired of juggling multiple health portals? Pixel Health's new AI-powered platform, One Thread, aims to unify the patient journey into a single experience.

A Cayman Islands court ruling reveals the crucial role of software experts in resolving a multi-million dollar tech-sector corporate governance dispute.

Relm is tackling the tech talent gap with new scholarships at the University of Miami and in Bermuda, creating pathways into emerging risk sectors.